Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the rabbit model of sinusitis

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 6, 2004, Pages 477-482

  Karasen, R Murat ^a,b,c   Uslu, Celil ^a,b   Taysi, Seyithan ^a,b   Gundogdu, Cemal ^a,b   Akcay, Fatih ^a,b  

^a Atatürk University ^*

^b ATATURK UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Animal model of sinusitis; Nitric oxide; Platelet activating factor; WEB 2170 BS

Indexed keywords

BEPAFANT; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; HISTOPATHOLOGY; INFLAMMATORY CELL; MAXILLA SINUSITIS; MAXILLARY SINUS; MOUSE; MUCOCILIARY TRANSPORT; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RABBIT; SINUSITIS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 2942654730     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300612     Document Type: Article

References (31)

1. Hurley DB, Smith GS, Vogler GA, Desponde Y, Citardi MJ. Leukotriene B4 levels in rabbit maxillary sinusitis: limitations of the current model. Am J Rhinol 2001;15:47-8.
2. Norlander T, Westrin KM, Stierna P. The inflammatory response of the sinus and nasal mucosa during sinusitis: implications for research and therapy. Acta Otolaryngol Suppl (Stockh) 1994(suppl 515):38-44.
3. Marks SC. Acute sinusitis in the rabbit model: histologic analysis. Laryngoscope 1998;108:320-5.
4. Stierna P, Kumlien J, Carlsoo B. Experimental sinusitis in rabbits induced by aerobic and anaerobic bacteria: models for research in sinusitis. J Otolaryngol 1991;20:376-8.
5. McManus LM. Pathobiology of platelet-activating factors. Pathol Immunopathol Res 1986;5:104-17.
6. Barnes PJ, Chung KF, Page CP. Platelet-activating factors as a mediator of allergic disease. J Allergy Clin Immunol 1998;81:919-34.
7. Jeon SY, Kim EA, Ma YW, Kim JP, Jung TG, Hwang EG. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. Ann Otol Rhinol Laryngol 2001;110:83-6.
8. Rhee CK, Jung TTK, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993;102:600-5.
9. Ganbo T, Hisamatsu K. Mucosal dysfunction and damage induced by platelet activating factor (PAF). Acta Otolaryngol (Stockh) 1990;110:427-36.
10. Karasen RM, Sutbeyaz Y, Aktan B, Ozdemir H, Gundogdu C. Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol 2000;109:549-53.
11. Casals-Stenzel J, Muacevic G, Weber KH. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther 1987;241:974-81. [Erratum in J Pharmacol Exp Ther 1988;245:749.]
12. Casals-Stenzel J, Muacevic G, Weber KH. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther 1987;241:974-81. [Erratum in J Pharmacol Exp Ther 1988;245:749.]
13. Casals-Stenzel J, Weber KH. Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. Br J Pharmacol 1987;90:139-46.
14. Heuer HO. Pharmacology of hetrazepines as PAF-antagonists. In: Braquet P, ed. Handbook of PAF and PAF antagonists. Boca Raton, Fla: CRC Press, 1991:171-202.
15. Yin ZL, Hickey H, Dusting GJ. Aplatelet-activating factor antagonist (WEB 2170) preserves endothelium-dependent vasodilatation and prevents development of a neo-intima induced by a periarterial collar in rabbit carotid arteries. J Vasc Res 1998;35:156-64.
16. Djupesland PG, Chatkin JM, Qian W, Haight JS. Nitric oxide in the nasal airway: a new dimension in otorhinolaryngology. Am J Otolaryngol 2001;22:19-32.
17. Lefevere L, Willems T, Lindberg S, Jorissen M. Nasal nitric oxide. Acta Otorhinolaryngol Belg 2000;54:271-80.
18. Baraldi E, Azzolin NM, Biban P, Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997;155:1680-3.
19. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998;53:680-4.
20. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998;12:1290-4.
21. Kim CS, Jeon SY, Min YG, et al. Effects of beta-toxin of Staphylococcus aureus on ciliary activity of nasal epithelial cells. Laryngoscope 2000;110:2085-8.
22. Durak I, Kavutcu M, Kacmaz M, et al. Effects of isoflurane on nitric oxide metabolism and oxidant status of guinea pig myocardium. Acta Anaesthesiol Scand 2001;45:119-22.
23. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 1995;41:904-7.
24. Lowry O, Rosenbraugh N, Farr L, Randall R. Protein measurement with folin phenol reagent. J Biol Chem 1951;182:265-75.
25. Cable BB, Wassmuth Z, Mann EA, et al. The effect of corticosteroids in the treatment of experimental sinusitis. Am J Rhinol 2000;14:217-22.
26. Jeon S-Y, Jeong P-S, Rhee C-K, Min Y-G. Ultrastructural changes in platelet activating factor-induced epithelial damage in rabbit maxillary sinus mucosa. Ann Otol Rhinol Laryngol 2000;109:726-30.
27. Rhee C-K, Jeong P-S, Kim Y-H, Chung P-S, Jung TTK. Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. Ann Otol Rhinol Laryngol 1999;108:453-8.
28. Ramirez MM, Quardt SM, Kim D, Oshiro H, Minnicozzi M, Duran WN. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res 1995;50:223-34.
29. Klabunde RE, Anderson DE. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. J Vasc Res 2002;39:238-45.
30. Schlosser RJ, Spotnitz WD, Peters EJ, Fang K, Gaston B, Gross CW. Elevated nitric oxide metabolite levels in chronic sinusitis. Otolaryngol Head Neck Surg 2000;123:357-62.
31. Furukawa K, Harrison DG, Saleh D, Shennib H, Chagnon FP, Giaid A. Expression of nitric oxide synthase in the human nasal mucosa. Am J Respir Crit Care Med 1996;153:847-50.